Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Lutterotti

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Brain : a Journal of Neurology|May 24, 2003
A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesionsHans Lassmann, Markus Reindl, Helmut Rauschka, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2021
T-Cell Specificity Influences Disease Heterogeneity in Multiple SclerosisCarolina Cruciani, Marco Puthenparampil, Paula Tomas-Ojer, et al.
Science Translational Medicine|June 7, 2013
Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosisAndreas Lutterotti, Sara Yousef, Andreas Sputtek, et al.
Journal of Neuroimmunology|October 7, 2015
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trialRainer Ehling, Franziska Di Pauli, Peter Lackner, et al.
Journal of Neuroinflammation|October 27, 2017
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelinationPatrick Peschl, Kathrin Schanda, Bleranda Zeka, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch StudyClaudia Gneiss, Pia-Maria Koudouovoh-Tripp, Stefan Ropele, et al.
Stroke|October 15, 2020
Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case SeriesEmanuela Keller, Giovanna Brandi, Sebastian Winklhofer, et al.
Journal of Neuroinflammation|December 30, 2011
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disordersSimone Mader, Viktoria Gredler, Kathrin Schanda, et al.
Neurology|February 27, 2020
Autoantibodies against the prion protein in individuals with <i>PRNP</i> mutationsKarl Frontzek, Manfredi Carta, Marco Losa, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 21, 2016
Restoring immune tolerance in neuromyelitis optica: Part ILarry Steinman, Amit Bar-Or, Jacinta M Behne, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Brain : a Journal of Neurology|May 24, 2003
A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesionsHans Lassmann, Markus Reindl, Helmut Rauschka, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2021
T-Cell Specificity Influences Disease Heterogeneity in Multiple SclerosisCarolina Cruciani, Marco Puthenparampil, Paula Tomas-Ojer, et al.
Science Translational Medicine|June 7, 2013
Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosisAndreas Lutterotti, Sara Yousef, Andreas Sputtek, et al.
Journal of Neuroimmunology|October 7, 2015
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trialRainer Ehling, Franziska Di Pauli, Peter Lackner, et al.
Journal of Neuroinflammation|October 27, 2017
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelinationPatrick Peschl, Kathrin Schanda, Bleranda Zeka, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch StudyClaudia Gneiss, Pia-Maria Koudouovoh-Tripp, Stefan Ropele, et al.
Stroke|October 15, 2020
Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case SeriesEmanuela Keller, Giovanna Brandi, Sebastian Winklhofer, et al.
Journal of Neuroinflammation|December 30, 2011
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disordersSimone Mader, Viktoria Gredler, Kathrin Schanda, et al.
Neurology|February 27, 2020
Autoantibodies against the prion protein in individuals with <i>PRNP</i> mutationsKarl Frontzek, Manfredi Carta, Marco Losa, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 21, 2016
Restoring immune tolerance in neuromyelitis optica: Part ILarry Steinman, Amit Bar-Or, Jacinta M Behne, et al.
Pageof 7